COMPARISON OF EFFICACY OF FIXED-DOSE ROSUVASTATIN PLUS EZETIMIBE COMBINATION THERAPY VERSUS ROSUVASTATIN MONOTHERAPY IN CORONARY ARTERY DISEASE PATIENTS. RMSR. 2025;3(7):1936-1942. Accessed July 25, 2026. https://medicalsciencereview.com/index.php/Journal/article/view/1865